What is Anosognosia and Why Does it Matter in Dementia Care?
Anosognosia is a neurological condition in which a person is unaware that they have a particular disease. For people living with Alzheimer’s disease and…
Anosognosia is a neurological condition in which a person is unaware that they have a particular disease. For people living with Alzheimer’s disease and…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. For 25 years, Mark…
Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine…
There’s no set amount of sleep you need. Everyone’s a bit different. But to have a healthy brain, one thing’s certain: You need good,…
More than one in ten people who catch COVID don’t fully recover — developing a chronic condition called long COVID which causes a variety…
With scientists studying if new semaglutide weight loss drugs could potentially treat dementia, many have questions about the potential impact of Ozempic and Wegovy…
Members of the Being Patient community are increasingly curious to learn their genetic status as it relates to Alzheimer’s risk. A story I was…
Dementia is not an inevitable consequence of aging. It’s thought that around 40 percent of dementia cases could be prevented (or at least delayed)…
When entrepreneur and futurist Maddy Dychtwald took a careful look at the longevity space, she found there were very few books out there tailored…
What if reducing your dementia risk could be as simple as owning a dog? Several observational studies published last year suggest pet ownership could…
Stressful life events, such as the death of a loved one or divorce, put a person at greater risk of developing dementia in later…
After actor Lauren Miller Rogen’s mother was diagnosed with Alzheimer’s, she and her husband, actor Seth Rogen, decided to apply their powers of entertainment…
In the past year, the FDA approved two landmark new Alzheimer’s drugs: monoclonal antibodies designed to attack the disease’s underlying pathology, as opposed to…
There are more than 500 active clinical trials for Alzheimer’s and other dementias in the U.S. They are designed to test different interventions, such…
Clinical trials and studies scientific experiments that investigate new treatments, lifestyle interventions, or risk factors for developing a disease like Alzheimer’s or dementia. By…